Form 4: Baker Hughes CEO Exercises Options, Sells Shares
Insider Transaction Report
Baker Hughes Chairman, President, and CEO Lorenzo Simonelli exercised stock options and subsequently sold a portion of his Class A Common Stock under a pre-arranged 10b5-1 trading plan.
Summary
- Lorenzo Simonelli, Chairman, President, and CEO of Baker Hughes Co (BKR), engaged in an insider transaction on March 4, 2026.
- Simonelli exercised stock options to acquire 187,343 shares of Class A Common Stock at an exercise price of $35.7 per share.
- Following the option exercise, Simonelli sold 272,593 shares of Class A Common Stock at a weighted average price of $61.13 per share.
- The sale price ranged from $60.54 to $62.28 per share.
- These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
- After these transactions, Simonelli directly beneficially owns 672,810 shares of Class A Common Stock.
- He also directly beneficially owns 187,344 derivative securities (stock options) with an expiration date of August 1, 2027.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it involves insider selling, the transaction was pre-planned under a 10b5-1 plan, which is a routine part of executive compensation and personal financial management. The executive also realized a significant profit, which is a positive for the individual.
Positives
- The executive realized a significant profit from exercising options at $35.7 and selling shares at a weighted average of $61.13, demonstrating effective personal financial planning.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating transparency and mitigating concerns about opportunistic insider trading.
Negatives
- The sale of a substantial number of shares by a key executive, even if pre-planned, could be perceived by some investors as a lack of conviction, though this is a common practice for executive compensation.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those involving the exercise of stock options and subsequent sale of shares, are a common component of executive compensation and personal financial planning. The use of a Rule 10b5-1 trading plan is standard practice for executives to manage their equity holdings in a compliant and transparent manner, reducing the risk of insider trading allegations.
Comparison to Industry Standards
- The use of a Rule 10b5-1 trading plan aligns with best practices for corporate governance and insider trading compliance, commonly adopted by executives across publicly traded companies to pre-arrange stock transactions.
- The profit realized from the option exercise and sale is typical for long-tenured executives whose compensation packages often include equity incentives designed to align their interests with shareholders over time.
Stakeholder Impact
- Shareholders: May note the executive's sale of shares, but the pre-planned nature under a 10b5-1 plan generally mitigates concerns about negative sentiment. It reflects a routine compensation event.
Key Dates
| Date | Description |
|---|---|
| 08/01/2017 | Stock option grant date. |
| 11/10/2025 | Rule 10b5-1 trading plan adoption date by the reporting person. |
| 03/04/2026 | Date of option exercise and subsequent sale of Class A Common Stock. |
| 03/06/2026 | Signature date of the reporting person's attorney-in-fact on the filing. |
| 08/01/2027 | Expiration date of the remaining stock options. |
Recommendation
holdThis Form 4 filing details a routine, pre-planned insider transaction involving the exercise of stock options and subsequent sale of shares by a key executive. Such transactions, especially when conducted under a Rule 10b5-1 plan, typically do not indicate a change in the company's fundamental outlook or warrant a shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information that would significantly alter the investment thesis for Baker Hughes Co.
Keywords
Baker Hughes, BKR, Lorenzo Simonelli, Insider Transaction, Form 4, Stock Options, Share Sale, 10b5-1 Plan, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.